Molecules 2010, 15(9), 5878-5908; doi:10.3390/molecules15095878
Review

Discovery and Development of Anti-HBV Agents and Their Resistance

Kyun-Hwan Kim 1,2,* email, Nam Doo Kim 3  and Baik-Lin Seong 4,5,* email
1 Department of Pharmacology, School of Medicine, and Center for Cancer Research and Diagnostic Medicine, IBST, Konkuk University, Seoul 143-701, Korea 2 Research Institute of Medical Sciences, Konkuk University, Seoul 143-701, Korea 3 R&D Center, Equispharm Inc., 11F Gyeonggi Bio-Center, 864-1 Iui-Dong, Yeongtong-gu, Suwon-Shi, Gyeonggi-Do 443-766, Korea 4 Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea 5 Translational Research Center for Protein Function Control, Yonsei University, Seoul 120-749, Korea
* Authors to whom correspondence should be addressed.
Received: 4 August 2010; in revised form: 24 August 2010 / Accepted: 26 August 2010 / Published: 27 August 2010
(This article belongs to the Special Issue Anti-Infective Agents)
PDF Full-text Download PDF Full-Text [642 KB, uploaded 27 August 2010 16:18 CEST]
Abstract: Hepatitis B virus (HBV) infection is a prime cause of liver diseases such as hepatitis, cirrhosis and hepatocellular carcinoma. The current drugs clinically available are nucleot(s)ide analogues that inhibit viral reverse transcriptase activity. Most drugs of this class are reported to have viral resistance with breakthrough. Recent advances in methods for in silico virtual screening of chemical libraries, together with a better understanding of the resistance mechanisms of existing drugs have expedited the discovery and development of novel anti-viral drugs. This review summarizes the current status of knowledge about and viral resistance of HBV drugs, approaches for the development of novel drugs as well as new viral and host targets for future drugs.
Keywords: hepatitis B virus; antiviral agent; drug development; drug resistance; modeling; rational drug design

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Kim, K.-H.; Kim, N.D.; Seong, B.-L. Discovery and Development of Anti-HBV Agents and Their Resistance. Molecules 2010, 15, 5878-5908.

AMA Style

Kim K-H, Kim ND, Seong B-L. Discovery and Development of Anti-HBV Agents and Their Resistance. Molecules. 2010; 15(9):5878-5908.

Chicago/Turabian Style

Kim, Kyun-Hwan; Kim, Nam Doo; Seong, Baik-Lin. 2010. "Discovery and Development of Anti-HBV Agents and Their Resistance." Molecules 15, no. 9: 5878-5908.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert